Mereo BioPharma Group plc - American Depositary Shares — Cash Flow (NASDAQ:MREO) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities ———21.13 M32.83 M 32.71 M Cash from investing activities ———419 K699 K 20 K Cash from financing activities ———7.97 M46.15 M 248 K Free cash flow ———20.71 M32.13 M 32.39 M

News

Mereo BioPharma Group plc (MREO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Cantor Fitzgerald maintains Overweight rating on Mereo BioPharma stock

Needham lowers Mereo BioPharma stock price target to $3 on trial data

Five Below To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Tuesday - American Eagle Outfitters (NYSE:AEO), Apellis Pharmaceuticals (NASDAQ:APLS)

Mereo BioPharma updates setrusumab program, extends cash runway

BofA Securities lowers Ultragenyx Pharma stock price target on failed trials

Ultragenyx Pharma stock rating reiterated at Outperform by Leerink

Ultragenyx SVP Huizenga sells $2922 in shares

RARE, MREO Tank as Osteogenesis Study Fails to Meet Primary Endpoint

Why OceanFirst Financial Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - ACM Research (NASDAQ:ACMR), ADS-TEC Energy (NASDAQ:ADSE)

Jefferies lowers Ultragenyx Pharma stock price target to $63 on trial miss

Jefferies downgrades Mereo BioPharma stock to Hold after setrusumab trial failure